GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
FOCUS SUR L’ ACTIVITÉ ENVIRONNEMENT
BIOVITIS est spécialisée dans la production de flores fongiques et bactériennes pour le traitement d’environnements
pollués.
Les champignons filamenteux produisent des complexes enzymatiques particulièrement performants, capables de
biodégrader une large gamme de molécules organiques complexes souvent hautement toxiques pour une population
bactérienne. Ils améliorent ainsi les performances des traitements biologiques soit en participant directement à l’élimi-
nation des composés polluants, soit en protégeant une flore microbienne active par dégradation de composés toxiques.
BIOVITIS propose des solutions microbiennes pour différentes applications.
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
PRINCIPALE UTILISATION DES MICROORGANISMES
Traitement et/ou clarification
des effluents urbains,
agricoles et industriels
Traitement de
composés polluants
Suppression des
mauvaises odeurs
Processus de compostage
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
LES SOLUTIONS BIOVITIS : LES PRODUITS MycoEpur®
MycoEpur® est une sélection de microorganismes non-OGM (bactéries vivantes et champignons) choisis pour leurs activités
enzymatiques. C’est un bio-additif naturel, livré sous forme liquide ou poudreuse.
BIOVITIS propose une gamme complète de produits standard développés par secteurs d’activité. Nous concevons également
des cocktails spécifiques et adaptés, par exemple pour les biomasses produites par des industries avec des procédés et des
fabrications uniques (chimie, pharmacie ...).
STATION D’ÉPURATION
INDUSTRIELLE
RESTAURATION
(DÉGRADATION DES GRAISSES) COMPOSTAGE
Augmentation rendement COD
Augmentation de la dégradation
problématique du composé
Réduction des
bactéries filamenteuses
Suppression des
croûtes de surface
Réduction de la maintenance
(moins de nettoyage)
Réduction des odeurs
Réduction des odeurs (COV)
Cinétique supérieure
de dégradation
(lignine / cellulose)
Augmentation des cycles de
production annuels
La bioaugmentation microbienne est spécifique à chaque traitement biologique.
Ainsi, nos ingénieurs sont disponibles pour analyser le fonctionnement de votre processus et vous offrir la meilleure
optimisation de votre outil.
GREENTECH
AN UNLIMITED RESOURCE
GREENTECH gathers its resources from every continent in order
to exploit the natural adaptive systems of regional species.
GREENTECH has uncovered over 300,000 bioactive molecules
across the world’s latitudes and longitudes, developed a hundred
active ingredients and over 3,000 extracts.
CUTTING EDGE RESEARCH
Researchers (one third of our staff) have for over 20 years shared
their scientific knowledge across all disciplines (plant biology,
botanical science, phytochemistry, microbiology, biochemistry,
chemistry, algology, nutrition, cosmetics, etc.).
The laboratory possesses its own data bank of over 30,000 botanicals
and 300,000 biological molecules.
High-tech processes used by the pharmaceutics industry transform
natural ingredients into actives: ethnobotany, bio-informatics with
molecular modelling, transcriptomic analysis (complete genome),
fermentation, a patented cryoextraction system that preserves
the plants’ active essence...
Mastery of high technologies witnessed by numerous quality
accreditations and awards.
Every year, over 15% of turnover is reinvested in R&D.
MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY
TO MEET THE TOMORROW’S CHALLENGES
GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally
innovative natural cosmetic active ingredients and extracts.
GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into
highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo
volunteer assays.
Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of
beneficial molecules for the skin thanks to an affinity with no equivalence.
A CUSTOMISED SERVICE, WITH EXCLUSIVE OR
PERSONALISED ACTIVE INGREDIENTS
GREENTECH develops specific, customised actives for the most
demanding brands in the market either exclusively or using
existing active ingredients that are adapted to their demands.
Reactivity and Flexibility are the master words in the company.
The GREENTECH’s factory produces in volumes of between
50 kg to 200 t.
A GROUP THAT IS THRIVING
Production site and international presence in constant development :
more than 10 000 m2, including 2000 m2 of laboratories equipped
with the most sophisticated active ingredients’extraction analysis,
stabilisation.
A HIGHLY COMMITTED GROUP, BUILT ON
SUSTAINABLE DEVELOPMENT AND FAIR TRADE
Confident that ethic is a source of progress, GREENTECH was
also a pioneer in being the first to adopt sustainable practices
and fair trade. It has forged long term partnerships based on
equal and mutual benefits: Madagascar, Peru, Burkina Faso…
Fully committed to the preservation of rare or threatened species,
Greentech collaborates with local communities in over 20 countries
around the world from the North and South poles to the Equator.
AN INFINITE SOURCE OF INNOVATIVE ASSETS
Harvested from the oceans and seas of the earth and in
sometimes extreme environments, macroalgae and marine
plants selected by GREENSEA present original cosmetic
activities, as well as microalgae produced under controlled
conditions. In addition to the extreme diversity of cultivated
species, the innovative technique of metabolic orientation
developed by GREENSEA makes it possible to create new
assets that meet the different needs of the skin and hair.
BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE
DEVELOPMENT
This unlimited biodiversity makes it possible to develop totally natural and
high-tech assets, sources of beauty, with a sustainable development philosophy
that is at the heart of GREENSEA and the GREENTECH GROUP.
ONE OF THE EUROPEAN LEADERS
The activity of GREENSEA is totally integrated, from the
culture tube to the commercial ingredient. Its large collection
of exotic and extremophilic microalgae and cyanobacteria,
its expertise in physiological stress for oriented microalgae
cultures, its industrial biological cultures in a controlled
environment, as well as its 100m³ production capacity on
3 types of closed systems, its quality assurance and the
reliability of its traceability make GREENSEA the reference
for microalgae in France and one of the European leaders.
A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active
ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the
world for cosmetics, pharmaceutics and nutraceutics.
A Group of companies dedicated to each biological universe:
BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into
innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus-
try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)
Active ingredients and extracts
derived from micro-algae,
algae and halophyte plants for
nutraceutics, dietetics, cosmetics,
immunodiagnostics and aquaculture.
MARINE
Active ingredients and extracts
derived from plants and
biotechnologies for nutraceutics,
pharmaceutics and cosmetics.
BOTANICAL
Biovitis
Microbial biotechnology
for nutritional, agronomic,
pharmaceutical, dermocosmetic
and environmental purposes.
MICROBIAL
Active ingredients derived from
Brazilian biodiversity for the
cosmetics, pharmaceutics and
nutraceutics markets.
BRAZILIAN BIODIVERSITY
A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS
BIOVITIS
Expert en biotechnologie
et écologie microbienne